Emmaus Life Sciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Emmaus Life Sciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 61% to $29,597,000. The net income raised on -$3,733,000 and profit margin reached -13%. Total operating expenses were $24,715,000.

Profit Margin

Emmaus Life Sciences, Inc. (OTC:EMMA): Profit margin
2014 135.1K -2.66M -1970.98%
2015 100.1K -3.37M -3376.02%
2016 85.1K -5.94M -6981.08%
2017 128.5K -7.11M -5535.25%
2018 1.31M -9.59M -729.66%
2019 22.75M -54.84M -241.04%
2020 23.16M 1.35M 5.84%
2021 20.61M -15.94M -77.37%
2022 18.39M -10.68M -58.1%
2023 29.59M -3.73M -12.61%

EMMA Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
29.59M18.39M20.61M23.16M22.75M1.31M128.5K85.1K100.1K135.1K
Cost of revenue
1.34M2.58M3.31M2.24M1.09M827.4K53.5K5.5K4.9K73K
Gross profit
28.25M15.80M17.29M20.91M21.65M488.1K75K79.6K95.2K62.1K
Operating exp.
Research and development
1.18M1.72M4.11M2.40M2.18M1.37M1.36M794.2K783.8K1.45M
Selling and marketing
8.63M7.49M5.87M4.86M6.97M1.99M1.39M550.5K347.9K390.2K
Total operating expenses
24.71M22.38M23.42M20.95M26.17M10.73M7.17M3.84M2.75M3.87M
Operating income
3.54M-6.58M-6.12M-43K-4.51M-10.24M-7.10M-3.76M-2.65M-3.81M
Other income (expenses), net
-7.33M-4.03M-9.79M1.00M-50.16M-86.3K-6.6K569.4K-724.6K1.16M
Income before tax
-3.79M-10.62M-15.92M719K-54.67M-10.33M-7.11M-5.93M-3.38M-2.65M
Income tax expense
-59K60K25K-381K164K1.9K2.6K2K5K5.2K
Net income
-3.73M-10.68M-15.94M1.35M-54.84M-9.59M-7.11M-5.94M-3.37M-2.66M
Earnings per share
Basic EPS
-0.07-0.22-0.320.02-1.3-11.08-15.15-55.54-39.83-32.17
Diluted EPS
-0.07-0.22-0.320.02-1.3-11.08-15.15-55.54-39.83-32.17
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source